Adam Cuker, MD, MTR
MTR Graduate, 2010
Current position: Assistant Professor of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine
Adam enrolled in the MTR pogram because "the course work was practical and applicable to (his) research. At the same time, meeting the requirements for graduation proved not to be an undue burden on (his) time and, in fact, increased the efficiency and methodologic rigor with which (he) was able to pursue (his) research." Throughout the program, Adam "was made aware of a number of critical resources for investigators throughout the institution that (he has) subsequently used for (his) own research." Adam identified the MTR degree as a valuable credential for grant applications and job searches.
Adam completed the degree while he was a Fellow in Hematology/Oncology at the Hospital of the University of Pennsylvania. After graduation, Adam was awarded a K23 grant from the NHLBI for his study, "Improving the Diagnosis of Heparin‐induced Thrombocytopenial."
Check out Adam's publications on PubMed.
Nuala Meyer, MD, MTR
MTR Graduate, 2011
Current Position: Assistant Professor of Medicine, Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pennsylvania Perelman School of Medicine
Before enrolling in the degree program, Nuala was in a basic science lab but aspired to do large scale genomic studies in human cohorts. She desired deeper training in clinical research, genetics, and informatics. For Nuala, the "MTR offered a flexible, personalized course of study to help (her) acquire specific skills helpful to (her) research, and simultaneously a comprehensive overview of clinical trial design, human subject protection, statistical methodology, and novel lab techniques. (She) found it quite invaluable to development as a translational researcher."
Nuala found the mentorship component of the program "supremely important" and helped her make contacts across the Penn community who are now her collaborators.
Nuala "would definitely recommend (the MTR degree program) to anyone interested in pursuing translational research, with a balanced approach to both the human population and to the molecular or imaging methodologies used. The program is best suited to someone with a clear idea of his/her research questions at the outset, and with a focused need for specific coursework."
Nuala completed the degree while she was an Instructor in Pulmonary, Allergy, and Critical Care Medicine at the Hospital of the University of Pennsylvania. After graduating, she was awarded a K23 from the NHLBI for her study, "Genetic Variation in the ANGPT-TIE Pathway and Risk for Acute Lung Injury."
Check out Nuala's publications on PubMed.
Nathan Singh, MD, MTR
MD-MTR Graduate, 2013
Current position: Internal Medicine Resident, Hospital of the University of Pennsylvania
Nathan enrolled in the MTR because he "wanted to really learn what translational research looks like - how it is structured and how physician-scientists can bridge this gap." Nathan found that the "landmarks set by the program, including proposal development and presentation, grant submission and thesis defense all forced (him) to continually move forward and re-evaluate progress in the lab, and provided an opportunity to receive feedback from experienced faculty." He described the feedback process as his "own private study section!"
Nathan was a combined degree student and completed the MTR degree in conjuction with medical school. While enrolled, Nathan was able to attend several professional conferences, give a talk at one of these conferences, and have exposure to leaders in the field. He described the MTR degree as helpful in residency interviews and residency placement. Even at an early stage in his career, he has submitted several small foundation grants and attributes part of this success to his MTR education.
Check out Nathan's publications on PubMed
2012 Matriculates ↓
|David Bajor, MD||Role of macrophages in pancreatic ductal adenocarcinoma in mice and humans||Robert H. Vonderheide, MD, DPhil|
|Ann-Marie Chacko, PhD||Developing 124Immuno-PET Diagnostics to Glioblastoma Multiforme Through Tumor Endothelial Marker-1||Vladimir Muzykantov, MD, PhD|
|Nadya Clarke, MD||Electrospun Nanofibers as a Pro- Angiogenic Periosteal Like Supplement to Calvarial Bone Regeneration||Hyun-Duck Nah-Cederquist, DMD, PhD|
|Lauren Fishbein, MD, PhD||Understanding Tumorigenesis in Pheochromocytomas and Paragangliomas||Katherine L. Nathanson, MD|
|Al Garfall, MD||Cellular Immunotherapy for Multiple Myeloma||Edward A. Stadtmauer, MD, Martin Carroll MD|
|Michael Grandner, PhD||Short Sleep Duration and Cardiometabolic Disease Risk||Allan Pack, MBChB, PhD|
|David Irwin, MD||Improving the Ante Mortem Diagnostic Accuracy in the Behavioral Variant of Frontotemporal Lobar Degeneration||John Trojanowski, MD, PhD, Murray Grossman, MD, EdD|
|Brian Kim, MD||Group 2 innate lymphoid cells promote atopic dermatitis-like disease||David Artis, PhD|
|Stuart Kinsella, MD student||Development of a Large Animal Model of Osteochondritis Dissecans||Robert Mauck, PhD|
|Daniel Larach, MD student||Deep Phenotyping of Subjects with Novel Genetic Variants Associated with Unusual Lipid Levels||Daniel Rader, MD|
|John Macarthur, MD||Directed Delivery of Engineered Stromal Cell-Derived Factor-1α (SDF) Analogue; Effects on Angiogenesis and Ventricular Function in an Ovine Model of Ischemic Cardiomyopathy||Y. Joseph Woo, MD|
|Jon Quatromoni, MD Student||Characterization of Immunosuppressive Myeloid Cells in Lung Cancer Patients||Sunil Singhal, MD|
|Kathleen Sturgeon, PhD||Mitigation of Cardiotoxicity in Breast Cancer Patients||Kathryn Schmitz, PhD, MPH|
|Jessica Wen, MD||Maternal-fetal transmission of hepatitis C virus and early viral diversification by single genome sequencing||George M. Shaw, MD, PhD|
|Jason Wink||Sustained Delivery of Bone Morphogenetic Protein-2 to the Craniofacial Skeleton||Hyun-Duck Nah Cederquist, DMD, PHD|
2013 Matriculates ↓
|Mark Attiah, MD Student||Functional Neurosurgery||Timothy Lucas, MD, PhD|
|Danielle Brewington, MD Student||Combination BRAF inhibition in Pediatric Gliomas||Adam Resnick, PhD|
|Philip Haines, MD, MPH||Structural and Functional Myocardial remodeling - role of myocardial fibrosis and COX-2 signaling||Garret FitzGerald, MD, Rick Assoian, PhD|
|Erum Hartung, MD||Pediatric Nephrology - Autosomal Recessive Polycystic Kidney Disease||Susan Furth, MD, PhD|
|Ray Hu, MD Student||Integrative Genomics in human myocardial cells to identify therapeutic targets||Tom Cappola, MD|
|Melody Ju, MD Student||Characterization of circulating tumor cells using telomerase activity assay in melanoma||Gary Kao, MD, PhD|
|Jennifer Kalish, MD, PhD||The mechanism of tumor formation in Beckwith-Wiedemann Syndrome and sporadic cancers with similar genetic changes||Marisa Bartolomei, PhD|
|Jennie Lin, MD||Translational studies in the treatment of Acute Kidney Injury (AKI)||Muredach Reilly, MBBCH, Larry Holzman, MD|
|Shana McCormack, MD||Premature Adrenarche: Interaction of Genetic Variation, Nutrient Availability, and Insulin Signaling in Early Growth and Maturation||Virgina Stallings, MD|
|Kiyoyuki Miyasaka, MD||Clinical simulation facilities as avenue for research education, and medical device development||Rajesh Aggarwal, MD, PhD|
|Kathleen O'Neill, MD||Identification and modification of obesity-induced epigenetic changes in extraembryonic tissue||Rebecca Simmons, MD|
|Phillip Santoiemma, MD Student||Immune-Based Cancer Therapy||Daniel Powell Jr., PhD|
|Jasmeet Singh, MD, MPHA||Use of transcranial doppler in studying microemboli and use of PET Scan in studying right ventricle metabolism in pulmonary hypertension||Yuchi Han, MD, MMSc|
|Christina Twyman-St. Victor, MD||Translational Studies in the Treatment of Metastatic Melanoma||Andy Minn, MD, PhD|
|Payman Zamani, MD||The Effects of Verapamil in Heart Failure with Preserved Ejection Fraction||Julio Chirinos, MD|